← All organizations

Syne Qua Non Limited

For profitWebsite ↗

Also known as: Syne Qua Non Limited

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 11, 2019

Timeline

1990s

Jan 19, 1996
Syne Qua Non Limited— Founded

Drugs by trial phase (5 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

Fluciclovine

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

azathioprine

Indications

Studied for

Recent trials (6)

NCT03930264CollaboratorPhase 1Apr 11, 2019
NCT03252847CollaboratorPhase 1/Phase 2Jul 14, 2017
NCT03278873CollaboratorPhase 1/Phase 2Jun 27, 2017
NCT02946879CollaboratorPhase 1/Phase 2Nov 1, 2016
NCT02680041CollaboratorPhase 3May 1, 2016
NCT02578940CollaboratorPhase 3Nov 1, 2015

Details

Founded: Diss, GB Jan 19, 1996
Last known activity: Apr 11, 2019

Notes

CRO